Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.
暂无分享,去创建一个
M. Colombel | O. Rouvière | M. Rabilloud | A. Chesnais | E. Niaf | F. Bratan | F. Mege-Lechevallier | S. Roche | O Rouvière | M Rabilloud | M Colombel | F Bratan | F Mège-Lechevallier | A L Chesnais | E Niaf | S Roche | Emilie Niaf
[1] Aytekin Oto,et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.
[2] Laura Curiel,et al. Influence of perfusion on high‐intensity focused ultrasound prostate ablation: A first‐pass MRI study , 2007, Magnetic resonance in medicine.
[3] Cher Heng Tan,et al. Diffusion weighted imaging in prostate cancer , 2011, European Radiology.
[4] J. McNeal,et al. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume , 2001, The Prostate.
[5] Valeria Panebianco,et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.
[6] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[7] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[8] Carole Lartizien,et al. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI , 2012, Physics in medicine and biology.
[9] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[10] Thomas Hambrock,et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.
[11] Aytekin Oto,et al. Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging. , 2010, World journal of radiology.
[12] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[13] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[14] Olivier Rouvière,et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.
[15] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[16] Olivier Rouvière,et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging , 2003, European Radiology.
[17] A. Villers,et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.
[18] M. Colombel,et al. Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI? , 2012, European Radiology.
[19] M. Moche,et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values , 2012, European Radiology.
[20] A. Villers,et al. Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology , 2009, The Prostate.
[21] J. K. Kim,et al. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. , 2011, AJR. American journal of roentgenology.
[22] Emilie Niaf,et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study , 2013, European Radiology.
[23] Baris Turkbey,et al. Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.
[24] Hiroshi Honda,et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.
[25] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[26] Jason A Koutcher,et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.
[27] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[28] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.
[29] Y. Yamashita,et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.
[30] Clare Allen,et al. Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.
[31] Xavier Leroy,et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.
[32] Yuri Kitamura,et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.